会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 71. 发明授权
    • Aminoguanidines and alkoxyguanidines as protease inhibitors
    • 氨基胍和烷氧基胍作为蛋白酶抑制剂
    • US06235778B1
    • 2001-05-22
    • US08979234
    • 1997-11-26
    • Bruce E. TomczukRichard M. SollTianbao LuCynthia L. FeddeCarl R. IlligThomas P. MarkotanThomas P. Stagnaro
    • Bruce E. TomczukRichard M. SollTianbao LuCynthia L. FeddeCarl R. IlligThomas P. MarkotanThomas P. Stagnaro
    • A61K31255
    • C07C309/73C07C309/75C07C309/76C07C309/77C07C311/16C07C311/17C07C311/18C07C311/19C07C311/21C07C317/14C07C323/66C07C2601/02C07C2601/14C07D211/96C07D213/42C07D213/74C07D215/36C07D217/02C07D217/22C07D239/42C07D295/13C07D295/26C07D307/66
    • Aminoguanidine and alkoxyguanidine compounds, including compounds of the formula: wherein X is O or NR9 and R114 R4, R6-R9, R11, R12, Ra, Rb, Rc, Y, Z, n and mare set forth in the specification, as well as hydrates, solvates or pharmaceutically acceptable salts thereof, that inhibit proteolytic enzymes such as thrombin are described. Also described are methods for preparing the compounds of Formula I. The novel compounds of the present invention are potent inhibitors of proteases, especially trypsin-like serine proteases, such as chymotrypsin, trypsin, thrombin, plasmin and factor Xa. Certain of the compounds exhibit antithrombotic activity via direct, selective inhibition of thrombin, or are intermediates useful for forming compounds having antithrombotic activity. The invention includes a composition for inhibiting loss of blood platelets, inhibiting formation of blood platelet aggregates, inhibiting formation of fibrin, inhibiting thrombus formation, and inhibiting embolus formation in a mammal, comprising a compound of the invention in a pharmaceutically acceptable carrier. Other uses of compounds of the invention are as anticoagulants either embedded in or physically linked to materials used in the manufacture of devices used in blood collection, blood circulation, and blood storage, such as catheters, blood dialysis machines, blood collection syringes and tubes, blood lines and stents.
    • 氨基胍和烷氧基胍化合物,包括下式的化合物:其中X是O或NR9,R114R4,R6-R9,R11,R12,Ra,Rb,Rc,Y,Z,n和母本也在说明书中列出 描述了抑制蛋白水解酶如凝血酶的水合物,溶剂合物或其药学上可接受的盐。 还描述了制备式I化合物的方法。本发明的新化合物是蛋白酶的有效抑制剂,特别是胰蛋白酶样丝氨酸蛋白酶,例如胰凝乳蛋白酶,胰蛋白酶,凝血酶,纤溶酶和因子Xa。 某些化合物通过直接,选择性抑制凝血酶表现出抗血栓形成活性,或者是用于形成具有抗血栓形成活性的化合物的中间体。 本发明包括用于抑制血小板损失,抑制血小板聚集体形成,抑制纤维蛋白形成,抑制血栓形成和抑制哺乳动物栓塞形成的组合物,其包含本发明化合物在药学上可接受的载体中。 本发明化合物的其它用途是作为凝血剂或者物理连接于制造用于血液收集,血液循环和血液储存中的装置的材料的抗凝剂,例如导管,血液透析机,采血注射器和管, 血线和支架。